Dosage units of 3-(6-(1-(2,2-difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

Details for Australian Patent Application No. 2009296271 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Young, Christopher

Agent Baldwins

Pub. Number AU-A-2009296271

PCT Pub. Number WO2010/037066

Priority 61/163,629 26.03.09 US; 61/100,787 29.09.08 US

Filing date 29 September 2009

Wipo publication date 1 April 2010

International Classifications

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/443 (2006.01)

Event Publications

7 April 2011 PCT application entered the National Phase

  PCT publication WO2010/037066 Priority application(s): WO2010/037066

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009296275-Foldable package

2009296268-Plasmodium vaccines, antigens, compositions and methods